Universal Health upgraded to buy by Mizuho
Mizuho Securities upgraded Universal Health Services (NYSE: UHS) from Neutral to Buy with a price target of $138.00 (from $133.00).
Analyst Ann Hynes comments “With the collapse of the proposed legislation, the ACHA, we think earnings visibility improves. We are raising our price target to $138 from $133, driven by the increase in the forward EV/EBTIDA multiple (to 8.0x from 7.0x) we put on the acute care business EBITDA in our sum-of-the-parts analysis. We think UHS’s acute care business deserves to trade at the 8.0x multiple given its industry leading same-store revenue trends of high-single digits.”